Michael Ryskin
Stock Analyst at B of A Securities
(1.47)
# 3,568
Out of 5,241 analysts
41
Total ratings
52%
Success rate
-2.05%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXRX Recursion Pharmaceuticals | Maintains: Neutral | $7 → $6 | $2.93 | +104.78% | 3 | Feb 26, 2026 | |
| ZTS Zoetis | Maintains: Neutral | $135 → $140 | $74.22 | +88.63% | 8 | Feb 13, 2026 | |
| SDGR Schrödinger | Upgrades: Buy | $24 | $11.95 | +100.84% | 3 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Buy | $110 → $99 | $93.97 | +5.35% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $43.93 | +59.34% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $528.79 | -10.17% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $4.15 | +92.77% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $157.25 | +31.00% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $94.92 | -57.86% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $0.79 | +1,108.34% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $24 | $4.48 | +435.71% | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $24 | $7.62 | +214.96% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $5.13 | +94.93% | 2 | Nov 10, 2021 |
Recursion Pharmaceuticals
Feb 26, 2026
Maintains: Neutral
Price Target: $7 → $6
Current: $2.93
Upside: +104.78%
Zoetis
Feb 13, 2026
Maintains: Neutral
Price Target: $135 → $140
Current: $74.22
Upside: +88.63%
Schrödinger
Dec 15, 2025
Upgrades: Buy
Price Target: $24
Current: $11.95
Upside: +100.84%
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $93.97
Upside: +5.35%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $43.93
Upside: +59.34%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $528.79
Upside: -10.17%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $4.15
Upside: +92.77%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $157.25
Upside: +31.00%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $94.92
Upside: -57.86%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $0.79
Upside: +1,108.34%
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $4.48
Upside: +435.71%
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $7.62
Upside: +214.96%
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $5.13
Upside: +94.93%